Safety and immunogenicity of a replication deficient simian adenoviral vectored chikungunya vaccine: A phase I, first-in-human, dose escalation trial
المؤلفون الرئيسيون: | , , , , , , , , , , , , , , , , , |
---|---|
التنسيق: | Conference item |
اللغة: | English |
منشور في: |
American Society of Tropical Medicine and Hygiene
2019
|